SEC Form 4 · accession 0001209191-17-016933
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Officer — EVP, Chief Business Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 28, 2017 | X | 6,913 | $4.308 | A | 127,216 | I | By Robert F. Carey III Trust dated 4/24/2001 |
| Ordinary Shares | Feb 28, 2017 | S | 1,808 | $16.48 | D | 125,408 | I | By Robert F. Carey III Trust dated 4/24/2001 |
| Ordinary Shares | Mar 1, 2017 | S | 30,000 | $16.00 | D | 95,408 | I | By Robert F. Carey III Trust dated 4/24/2001 |
| Ordinary SharesF3 | holding | — | — | — | 600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Ordinary Shares (Right to Buy) | $4.308 | Feb 28, 2017 | X | 6,913 | D | Mar 2, 2012 | Mar 2, 2017 | Ordinary Shares | 6,913 | 0 | I |
Explanation of responses
- F1Includes 38,242 shares which were transferred from the Reporting Person to the Trust on January 11, 2017.
- F2Exercise of a warrant to purchase 6,913 ordinary shares of the Issuer for $4.308 per share. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 1,808 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 5,105 shares. The warrant was scheduled to expire on March 2, 2017.
- F3On June 1, 2016, 1,173 ordinary shares of the Issuer were acquired by the reporting person pursuant to an employee stock purchase program. The number of Issuer shares previously reported as beneficially owned by the reporting person was incorrectly over reported on a prior Form 4 by 573 shares of the Issuer's common stock, and has been corrected with this filing.